补阳还五汤胶囊对AD大鼠NF-κB信号调控及对星形胶质细胞相关蛋白表达影响的实验研究
|
摘要
目的:本课题围绕NF-κB/IκB-α通路及星形胶质细胞理论观察补阳还五汤胶囊对老年性痴呆(AD)模型大鼠神经细胞的保护作用,并进一步探讨其作用机制。
方法:本课题采用大鼠单侧海马区定向注射Aβ1-40复制AD动物模型,观察补阳还五汤胶囊对AD模型大鼠的行为学的影响,通过HE染色及透射电镜观察病理形态学变化,并以酶联免疫法检测血清中Aβ1-40和β-APP含量的变化,通过免疫组化法检测对AD大鼠脑组织海马区NF-κBp65、IκB-α、GFAP和S100β蛋白表达的影响,此外还通过实时荧光定量PCR技术观察NF-κBp65mRNA、IκB-αmRNA和BACE1mRNA基因表达的影响,从行为学、细胞及分子水平探讨补阳还五汤胶囊对阿尔茨海默病的神经细胞保护作用。
结果:1.大鼠行为学实验显示补阳还五汤胶囊可以明显改善模型动物行为学的异常,提高学习记忆能力。2.补阳还五汤胶囊能改善病理因素造成的实验动物脑内的组织形态的异常。3.补阳还五汤胶囊能明显降低AD大鼠血清中Aβ1-40和β-APP含量。4.补阳还五汤胶囊能抑制AD大鼠大脑海马区中GFAP、S100β及NF-κBp65蛋白的表达,促进IκB-α蛋白的表达。5.补阳还五汤胶囊能促进AD大鼠大脑海马区IκB-αmRNA基因的表达,降低NF-κBp65mRNA及BACE1mRNA基因的表达。
结论:补阳还五汤胶囊对AD大鼠的神经元具有保护作用,其机理可能是通过降低AD大鼠的核转录因子NF-κBp65,从而抑制星形胶质细胞的增生并降低胶质细胞相关蛋白GFAP、S100β的表达,同时抑制BACE1的转录和翻译,降低对APP的活性,最终减少Aβ1-40的生成,从而达到预防并治疗痴呆的目的。
Objective: The issue surrounding the NF-κB / IκB-αpathway and the theory of astrocytes observed Buyang Huanwu Decoction capsule on Alzheimer's disease (AD) rat model nerve cell injury and further explore its mechanism.
Methods: Targeted by rats with bilateral hippocampal injection of Aβ1-40 to copy AD rat model , observed Buyang Huanwu Decoction capsule on behavior infection of AD rat model, observed morphological changes by HE staining and transmission electron microscopy , determined serum Aβ1-40 andβ-APP content changes by ELISA, determined NF-κBp65, IκB-α, GFAP and S100βprotein expression by immunohistochemistry, observed NF-κBp65mRNA, IκB-αmRNA and BACE1mRNA gene expression by Real time PCR , discussed Buyang Huanwu Decoction capsule protect effect nerve cells of AD from the Behavior, cellular and molecular level.
Result: 1. Rat behavior experiment Buyang Huanwu Decoction capsule can significantly improve the abnormal animal behavior models, improve learning and memory. 2. Buyang Huanwu Decoction capsule can improve the brain of experimental animals by pathological factors, the abnormal morphology. 3. Buyang Huanwu Decoction capsules can significantly reduce AD rat serum Aβ1-40 andβ-APP levels. 4. Buyang Huanwu Decoction capsule can inhibit the AD hippocampus of rat brain GFAP, S100βand NF-κBp65 protein expression, the promotion of IκB-αprotein. 5. Buyang Huanwu Decoction capsule can promote AD rat hippocampus IκB-αmRNA gene expression, decreased NF-κBp65mRNA and BACE1mRNA genes.
Conclusion: Buyang Huanwu Decoction capsule has a protective effect on rat neurons in AD, the mechanism may be the AD rats by reducing nuclear transcription factor NF-κBp65, thereby inhibiting the proliferation of astrocytes and reduced glial cell associated protein GFAP, S100βexpression, and inhibition of BACE1 transcription and translation of the APP activity and ultimately reduce the formation of Aβ1-40, thus preventing the occurrence and treatment of dementia.
方法:本课题采用大鼠单侧海马区定向注射Aβ1-40复制AD动物模型,观察补阳还五汤胶囊对AD模型大鼠的行为学的影响,通过HE染色及透射电镜观察病理形态学变化,并以酶联免疫法检测血清中Aβ1-40和β-APP含量的变化,通过免疫组化法检测对AD大鼠脑组织海马区NF-κBp65、IκB-α、GFAP和S100β蛋白表达的影响,此外还通过实时荧光定量PCR技术观察NF-κBp65mRNA、IκB-αmRNA和BACE1mRNA基因表达的影响,从行为学、细胞及分子水平探讨补阳还五汤胶囊对阿尔茨海默病的神经细胞保护作用。
结果:1.大鼠行为学实验显示补阳还五汤胶囊可以明显改善模型动物行为学的异常,提高学习记忆能力。2.补阳还五汤胶囊能改善病理因素造成的实验动物脑内的组织形态的异常。3.补阳还五汤胶囊能明显降低AD大鼠血清中Aβ1-40和β-APP含量。4.补阳还五汤胶囊能抑制AD大鼠大脑海马区中GFAP、S100β及NF-κBp65蛋白的表达,促进IκB-α蛋白的表达。5.补阳还五汤胶囊能促进AD大鼠大脑海马区IκB-αmRNA基因的表达,降低NF-κBp65mRNA及BACE1mRNA基因的表达。
结论:补阳还五汤胶囊对AD大鼠的神经元具有保护作用,其机理可能是通过降低AD大鼠的核转录因子NF-κBp65,从而抑制星形胶质细胞的增生并降低胶质细胞相关蛋白GFAP、S100β的表达,同时抑制BACE1的转录和翻译,降低对APP的活性,最终减少Aβ1-40的生成,从而达到预防并治疗痴呆的目的。
Objective: The issue surrounding the NF-κB / IκB-αpathway and the theory of astrocytes observed Buyang Huanwu Decoction capsule on Alzheimer's disease (AD) rat model nerve cell injury and further explore its mechanism.
Methods: Targeted by rats with bilateral hippocampal injection of Aβ1-40 to copy AD rat model , observed Buyang Huanwu Decoction capsule on behavior infection of AD rat model, observed morphological changes by HE staining and transmission electron microscopy , determined serum Aβ1-40 andβ-APP content changes by ELISA, determined NF-κBp65, IκB-α, GFAP and S100βprotein expression by immunohistochemistry, observed NF-κBp65mRNA, IκB-αmRNA and BACE1mRNA gene expression by Real time PCR , discussed Buyang Huanwu Decoction capsule protect effect nerve cells of AD from the Behavior, cellular and molecular level.
Result: 1. Rat behavior experiment Buyang Huanwu Decoction capsule can significantly improve the abnormal animal behavior models, improve learning and memory. 2. Buyang Huanwu Decoction capsule can improve the brain of experimental animals by pathological factors, the abnormal morphology. 3. Buyang Huanwu Decoction capsules can significantly reduce AD rat serum Aβ1-40 andβ-APP levels. 4. Buyang Huanwu Decoction capsule can inhibit the AD hippocampus of rat brain GFAP, S100βand NF-κBp65 protein expression, the promotion of IκB-αprotein. 5. Buyang Huanwu Decoction capsule can promote AD rat hippocampus IκB-αmRNA gene expression, decreased NF-κBp65mRNA and BACE1mRNA genes.
Conclusion: Buyang Huanwu Decoction capsule has a protective effect on rat neurons in AD, the mechanism may be the AD rats by reducing nuclear transcription factor NF-κBp65, thereby inhibiting the proliferation of astrocytes and reduced glial cell associated protein GFAP, S100βexpression, and inhibition of BACE1 transcription and translation of the APP activity and ultimately reduce the formation of Aβ1-40, thus preventing the occurrence and treatment of dementia.
引文
[1]陈俊抛,林煌.痴呆治疗学:新理论、新观点、新技术.北京:人民军医出版社,2002,第一版:99.
[2] Dufouil C,Alperobitch A.Epidemiology of Alzheimer's disease[J].Vev Prat,2oo5,55(17):1869-1878
[3] Zhang ZX,Zahner GE,Roman GC,et a1.Socio-demographic variation of dementia subtypes in China: methodology and results of a prevalence study in Beijing,Chengdu,Shanghai,and Xi'an.[J]. Neuroepidemiology,2006,27:177-187
[4]赵湘筠.髓海不足气魄神离—中医对老年性痴呆的认识.上海中医药杂志,1994,(5):24-25.
[5]张映梅.老年痴呆症虚实论治.云南中医中药杂志,2000,21 (6 ):37.
[6]滕晶.补肾化痰祛癖法治疗老年期痴呆机理探讨.河南中医,2003,23 (7):5.
[7]赵文研,陈荣.从脾论治老年性痴呆症.中医药学刊,2005年第23卷第9期:1666.
[8]欧阳真理.老年痴呆的病因病机探讨与治疗.中华实用中西医杂志,2005,18(13):212.
[9]孙明杰,于友华.清热解毒中药防治老年性痴呆症之理论探讨.中国中医基础医学杂志,2003,9 (2 ):17.
[10]郑丽,翟李娟.辨证分型治疗老年痴呆症30例疗效观察.河南中医学院学报,2004,19(4):113.
[11]姜哲浩,夏永良.老年性痴呆病因和发病机制的研究概况.辽宁中医杂志,2001,28(7):446-448
[12]郑丽,翟李娟.辨证分型治疗老年痴呆症30例疗效观察.河南中医学院学报,2004,19(4):113.
[13]赵奕虹,张琳.老年性痴呆辨证论治浅识.实用中医内科杂志,2005, 19 (3):222.
[14]李佰纲,韩秀兰,秦红艳.补肾益精汤治疗老年性痴呆96例.国医论坛,2000,15(3):34-35.
[15]赵文研,陈荣.从脾论治老年性痴呆症.中医药学刊,2005, 23 (9 ): 1665-1666.
[16]杨晓,谢东霞.补肾健脑丸治疗老年性痴呆92例.山西中医,2001, 17(4): 16-17.
[17]张新风.补肾填精汤治疗老年性痴呆30例临床观察.江西中医药,2005,36(12):23.
[18]蔡春华.加味左归丸治疗肝肾阴虚型老年痴呆31例.江苏中医,1994, 15 (11):9
[19]季光,胡梅.老年性痴呆中医治疗现状及展望.1994,7:332.
[20]盛树力,裴进京.老年性痴呆的临床和分子学基础[M].北京:科学技术文献出版社,1998
[21] Hauwj,etal.Alzheimer,5disease. In:Suektted[J]. The Pathologyofagingnervous Systern.London:leadF ebiger,1991,113
[22]Braa,etal.NeuroPathologiealstagingofAlzheimer一relatedehanges[J].AetaNeuroPathol.1991,82:239-256
[23]李求兵,梅荣.老年痴呆症的中西医诊断与治[M].北京:中国医药科技出版社,1999
[24] Liswixb J. A mechanism for the Hebb processes underlying learning and memory. Pro Nall Acard Sci USA,1989,86:9576.
[25] Jesus Avila, Mar Perez, Jose J, etal. Assembly In Vitro of Tau Protein and its implications in Alzheimer's Disease Current Alzheimer Research,2004, 1(7);97-101.
[26]高天理,冯立群,张茁.Tau蛋白在Alzheimer病病理机制中作用的研究进展.北京医学,2001, 23 (6) ; 365-367.
[27]江天,琦组和.载脂蛋白E与Alzheiner病的分子生物学研究新进展.中国老年医学杂志,1998, 17 (8) 8-189.
[28] Tomonaga M.et al.Numbers of Hirano bodies[J].Acta Neuropathol,1999,28:365-366.
[29] Sherns G, Sez Valero J, Beyreuther K, et al.The amyloid beta-protein of Alzheimer’s disease increase acetylcholinesterase carcinoma P19 cells. J Neurochem , 1997 ,69:1177-1184.
[30] Hoozemans JJ, Rozemuller AJ, Veerhuis R,Immunological aspects of alzheimer's disease: therapeutic impl icat ions. BioDrugs, 2001; 15(5):325-37
[31]姜哲浩,夏永良,李德新.老年性痴呆病因和发病机制的研究概况[J].辽宁中医杂志,2001,28(7 ) : 446-448
[32]杨文明,李泽庚,周宜轩,等.老年性痴呆病因及药物治疗[J].医学综述,2002,8(3):170-172
[33] Hauw JJ, et al,Alzheimer s disesse.In:Sucktted.The Pathology of aging nervous Systern.London: lea and Febiger,1991,113.
[34] Tabaton M,er al.Ultrastructural localization ofβ-amyoid,tau and ubiduitin epitopes in extracellular neurofibrillary tangles[J].Proe Natl Acad sci USA,1991,88:2098-2102.
[35] Bondareff E,et al.Molecular analysis of neurofibrillary degeneration in Alzheimer’s disease[J].Am J Pathol,2003,137:711-723
[36] Terry RD.Normal aging ang Alzhenmer’s disease:growing problems In: PA Cancilla,FVS Vohel and N Kaufman eds[J].Neropathology Baltimore:Willams ang Wilkins,1999,41-54.
[37] Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC:Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am JPathol 2004, 164:719-725.
[38] Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, ha H,Zhang J, Gong Y, et al: Mice deficient in BACE1, the lzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.Nat Neurosci 2001, 4:231-232.
[39] Mohaj eri MH, Saini KD, Nitsch RM:Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology. J Neural Transm 2004,111:413-425.
[40] Itagaki S,McGeer PL,Akiyama H,et al.Relationship of microglia and astrocytes to amyloid deposits of Alzheimer’s disease[J].J Neuroimmunol, 1989,24(3):173-182.
[41] Joshi SN,Crutcher KA.Rat microglia exhibit increased density on Alzheimer’s plaques in vitro[J].Exp Neurol,1998,149(1):42-50.
[42]魏桂荣,张敏,董继华,等.构建一种高产量小胶质细胞体外纯化培养的方法[J].中国临床康复,2005,9(21):208-210.
[43]陈青,刘传勇.星形胶质细胞的活化机制及功能研究.泰山医学院学报,2006,27:69-71.
[44] LH , YingTM , FangM , etal.Thediffereneein9110515indueedbyp amyloidandTau Treatmentsina stroeytecultures derivedfromseneseen ceaeeelerate dandnormal mouse strains.SPringerSeienee BusinessMediaB.V,2009(2).
[45] RobertGN,VenkatR,etal.Contributionofglialeellsto the evelo Pmentof amyloidPlaquesin Alzheimer,5disease.BrainResearch,2003,971:197-209.
[46] Stenzel W,Soltek S,Schlüter D,et a1·The interme-diate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis[J].J Neu-ropathol Exp Neurol,2004,63(6):631-640.
[47] Hoane M R,Wolyniak J G,Akstulewicz S L.Admin istration of riboflavin improves behavioral outcome and reduces edema formation and glial fibrillary acidicprotein expression after traumatic brain injury[J].J Neurotrauma,2005,22(10):1112-1122.
[48] Tanaka H,Katoh A,Oquro K,et al.Disturbance of hippocampals long-term potentiation after transient ischemia in GFAP deficient mice[J].J Neurosci Res, 2002,67(1):11-20.
[49] Endo T.Glycans and glycan-binding proteins in brain:galectin-1-induced expression of neurotrophic factors in astrocytes[J].Curr Drug Targets,2005,6(4):427-436.
[50] Nichols N R,Agolley D,Zieba M,et al·Glucocorticoid regulation of glial responses during hippocampal neu-rodegeneration and regeneration[J].Brain Res Brain Res Rev,2005,48(2):287-301.
[51] Temburni M K,Jacob M H.New functions for glia in the brain[J].Proc Natl Acad SciUSA,2001,98 (7):3631-3632.
[52] Min K J,Yang M S,Jou I,et al.Protein kinase A medi-ates microglial activation induced by plasminogen and gangliosides[J].Exp Mol
[53] Albrecht P J, Dahl J P, Stoltzfus O K, et al. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival [J].Exp Neurol,2002,173(1):46-62.Med,2004,36(5):461-467.
[54] Beattie E C,Stellwagen D,Morishita W,et al.Controlof synaptic strength by glial TNF alpha[J].Science, 2002,295(5563):2282-2285.
[55]王建彪,竺可青.星形胶质细胞对神经元作用的研究进展[J].浙江大学学报:医学版,2008,37(5):531-536.
[56] Soler AP,Thompson KA,Jarett L.Immunological demonstration of the accumulation of insulin,but not insulin receptors,in nuclei of insulin-treated cells.Proc Natl Acad Sci USA,1989,86:6640-6644.
[57] Harris ME Hensley K Butterfield DA,et al.Direct evidence of oxidative injury produced by the Alzheimer'sbeta-amyloid peptide(1-40)in cultured hippo cam palneurons. Exper Neuro[J].1 1995,131(2):193~200。
[58] Rogers SL,Doody R , et a1.E2020 produced both clinical global and cognitive testimprovement in patient with mild to moderately sever Alzheimer's disease: results of a30一weeks phaseIIItrial[J].Neurology,1996,(46):217.
[59] DAIE S,BARBOUR R,DUNN W,et al·Immunization with amyliod Battenuates Alzheimer disease-like pathology in the PDAPP mouse[J].Nature,1999,400(6740):173一177.
[60] Cynthia Lemere.notherapy for Alzheimer's Disease. Neurobiology of Aging, 2002 (23):986
[61] Blas Frangione. Modification of Soluble AβDerivativer: An Approach to Alzheimer's disease Therapy. Neurobiology of Aging, 2002, (23):987
[62] Martin Citron.β-Secretase Inhibitor Therapy for Alzheimer's as therapy for Alzheimer's Disease.Neurobiology of Aging, 2002, (23):991
[63] Sangram Sisodia.Current Status of Emerging Therapise for Alzheimer's Disease" Neurobiology of Aging,2002, (23):992
[64] Ashley Bush. Metal Complexing Agents as Therapies for Alzheimer;s Disease. Neurobiology of Aging,2002 (23):988
[65] Sam Gandy.Gonadal Hormones in the prevention of Alzheimer's disease. Neurobiology ofAging,2002,(23):989
[66] Virginia M. Y. Lee. Amyloid Binding Ligands as Alzheimer; s Disease Therapies. Neurobiology of Aging 2002, (23):990
[67] Sani S, Traul D, Klink A, et al. Distribution, progression and chemical composition of cortical amyloid-beta deposits in aged rhesus monkeys: similarities to the human. Acta Neuropathol(Beri), 2003,105(2): 145一156
[68] Nitta A, Itoh A, Hasegawa T,et al. 0 -amyloid protein induced Alzheimer's disease animal model.Neurosci Lett,1994,170(1):63-66
[69]崔行,王墨林,张群业.胆碱能系损伤老化鼠的脑神经肤表达与学习能力改变.中国老年学杂志,2002,22:379-381
[70] Giovannelli L,Cassamenti F,Scall C,et al. Differential effects of amyloid peptides p一(1-40) and一(25-35) injection into the rat mucles basalis. Neuroscience, 1995, 66:781一792
[71]程龙,田金州,黄启福.β一淀粉样蛋白所致拟AD大鼠模型行为学特征.中华医药杂志,2003,3(6)481-484
[72] Cakala M, Malik AR, Strosznajder JB. Inhibitor oof cyclooxygenase-2 protects against amyloid beta peptide-evoked memory impairment in mice. Pharmacol Rep, 2007,59(2):164-172
[73]林煌,王占军,陈俊抛,等.海马注射β一淀粉样蛋白对白介素-10和肿瘤坏死因子-a表达的影响及消炎痛的干预作用.中国神经免疫学和神经病学杂志,2002,9(1):21-24
[74] Kim HC, Yamada K, Nitta A, et al. Immunocy to chemical evidence that amyloid
[75] Deng HX, Siddique T. Transgenic Mouse Models and Human Neurodegenerative Disorder. Arch Neurol, 2000, 57(12):1695一1702
[76] Donald LP, Sangram SS. Cellular and molecular biology of Alzheimer's disease and animal models. Ann Rev Med, 1994,45:435-436
[77] Eilam D, Szechtman H, Faigon M, et al. Disintergration of the spaticalorganization of behavior in experimental autoimmune dementia. Neuroscience,1993,56:83一91
[78] Morris RG.Spatial localization does not require the presence of localcues[J].Learn Motiv,1981,12:239-60.
[79] Gallagher N,Nicolleo MM.Animal model of normal aging:relationship between congnitive decline and marker in hippocampal crcuity[J].Brain Research,1993,57:155-62
[80]DelacourteABueeL.Taupath01ogy:neurodegenerativedisorders.Curr.OPin.Neuro,2002,13,3712一3761
[81] Ball MJ.Neuronal loss,neurofibrillary tangles and granulovacuolar degeneration in the hippocampuuus with ageig brain and senile dementia .Aquantitative study[J].Acta Neuropathol,1977,37:111-118.
[82]蒋圣娟,孙振令,张红雨.阿尔茨海默氏症分子病理学及治疗方法的研究进展.山东理工大学学报(自然科学版),2003,17(1):94-99.
[83] DewachterI,VanDorpe J, SmeijersL, eta.l Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenicmice by a differentmechanism thanmutantpresenilin1·J Neurosc,i 2000,20(17):6452-6458.
[84] Kuo, Y.M., Beach, T. G., Sue, L. I., et a.l The evolution ofAβpeptide burden in the APP23 transgenic mice: implications forAβdeposition inAlzheimerdisease.Mo.lMed, 2001, 7:609-618.
[85] Kang J,Lemaire HG,Unterbeck A,et al.The precursor of Alzheimer’sdisease amyloidA4 protein resembles a cell surface receptor.Nature,1987,325:733~736
[86] Klein WL,Krafft GA,Finch CE.Targeting small Abeta oligomers:thesolution to an Alzheimer's disease conundrum?Trends Neurosci,2001,24(4):219~224
[87] Walsh DM,Klyubin I,Fadeeva JV,etal.Naturally secreted oligomers ofamyloid beta protein potently inhibit hippocampal long-term potentiationin vivo.Nature,2002,416(6880):535~539
[88] Cleary JP,Walsh DM,Hofmeister JJ,etal.Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function.Nat eurosci, 2005,8(1):79~84
[89] Hussain I,Powell D,Howlett DR,etal.Identification of a novel aspartic protease(Asp 2)as beta-secretase.Mol Cell Neurosci,1999,14(6):419~27
[90] Lin X,Koelsch G,Wu S,etal.Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.Proc Natl Acad Sci U S A,2000,97(4):1456~1460
[91] Sinha S,Anderson JP,Barbour R,etal.Purification and cloning of amyloid precursor protein beta-secretase from human brain.Nature,1999, 402(6761):537~540
[92] Cai H,Wang Y,McCarthy D,etal.BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.Nat Neurosci,2001,4(3):233~234
[93] Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, ha H,Zhang J, Gong Y, et al: Mice deficient in BACE1, the lzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.Nat Neurosci 2001, 4:231-232.
[94] Ingebrigtsen,Hughes S R,khorkova O,Goyal S,et al. Alpha-macrogloblin associates with b-amyloid peptide and prevents of fibril formation , proc Natl Acad Sci USA ,1998(95):3275-3280.
[95] Mucke L, Masliah E, Yu GQ, et al. High-level neuroal expression of abeta 1-42 in wild-type human amyloid protein precursor transgentic mice: synaptotoxicity without plaque formation. Neurosci ,2000,20:4050-4058.
[96] Yankner BA,Duffy LK,Kirschner DA.Neurotrophic and neurotoxic ef fects of amyloid protein:reversal by tachkinin neuropeptides.Science,1990,250(4978):279-282.
[97] Calderon FH, Bernhard R, et al. Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro. Mol Psychiarry,1998,3(3):247-255.
[98] Petrova,Terry RD. Basis of structural Alzheimer Disease and some pathogenic concepts. In:R Becker and E Giacobinieds.Alzheimer Disease: From molecular biology to therapy. Boston: Birkhauser,1997,19:25-28.
[99] Min K J,Yang M S,Jou I,et al.Protein kinase A medi ates microglial activation induced by plasminogen and gangliosides[J].Exp Mol Med,2004,36(5):461-467.
[100] Albrecht P J, Dahl J P, Stoltzfus O K, et al. Ciliary neurotrophic factor activates spinal cord astrocytes,stimulating their production and release of fibroblast growth factor-2,to increase motor neuron survival[J].Exp Neurol,2002,173(1):46-62.
[101] Beattie E C,Stellwagen D,Morishita W,et al.Control of synaptic strength by glial TNF alpha[J].Science,2002,295(5563):2282-2285.
[102]王建彪,竺可青.星形胶质细胞对神经元作用的研究进展[J].浙江大学学报:医学版,2008,37(5):531-536.
[103] Stenzel W,Soltek S,Schlüter D,et a1 The interme- diate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis[J].J Neuropathol Exp Neurol,2004,63(6):631-640.
[104] Hoane M R,Wolyniak J G,Akstulewicz S L.Admin istration of riboflavin improves behavioral outcome and reduces edema formation and glial fibrillary acidic protein expression after traumatic brain injury[J].JNeurotrauma,2005,22(10):1112-1122.
[105] Tanaka H,Katoh A,Oquro K,et al.Disturbance ofhippocampals long-term potentiation after transientischemia in GFAP deficient mice[J].J Neurosci Res,2002,67(1):11-20.
[106] Endo T.Glycans and glycan-binding proteins in brain:galectin-1-induced expression ofneurotrophic factors in astrocytes[J].Curr Drug Targets,2005,6(4):427-436.
[107] Nichols N R,Agolley D,Zieba M,et al·Glucocorticoid regulation of glial responses during hippocampal neurodegeneration and regeneration[J].Brain Res Brain Res Rev,2005,48 (2):287-301.
[108] Temburni M K,Jacob M H.New functions for glia in the brain[J].Proc Natl Acad Sci USA,2001,98 (7):3631-3632.
[109] O’Neill LAJ , Kaltschmidt C. NF - kB a crucial transcription factor forglial and neuronal cell function. Trends Neurosci ,1997 ,20 :252～258.
[110] Mattson MP,Culmsee C,Yu Z,Camandola S.Roles of nuclear factor kappaB inneuronal survival and plasticity[J].J Neurochem,2000,74:443-456
[111] Culmsee C,Siewe J,Junker V,Retiounskaia M,Schwarz S,Camandola S,et al.Reciprocal Inhibition of p53 and Nuclear Factor-κB Transcriptional Activities Determines Cell Survival or Death in Neurons[J].J Neurosci,2003,23:8586-8595.
[112] Middleton G,Davies AM,et al.Cytokine-induced Nuclear Factor Kappa BActivation Promotes the Survival of Developing Neurons[J].J Cell Biol,2000,148:325-332.
[113] Lilienbaum A,Isra?l A.From Calcium to NF-B Signaling Pathways in Neurons[J].Mol Cell Biol,2003,23:2680-2698.
[114] Boissiere F ,Hunot S ,Faucheaux B et al . Nuclear translocation of NF -kappa B in cholinergic neurons of patients with Alzhecmer’s disease.Neuroreport ,1997 ,8(13) :2849～2852
[115]冯凯琳,陈宝友,陈彦亭等.核转录因子NF - kB与中枢神经系统疾病[J].武警医学.2002.4:236 [ 116] M aurelD, SageD. M ekaoucheM, eta.l Glucocorticoids up - regu-late the expression of glial f ibrillary acidic protein in the rat suprachi-asm atic nucleus[J].Glia, 2000, 29 (3): 212.
[117] Selkoe DJ. American college of physicians, American physiologi-calsociety. Alzheimer disease:mechanistic understanding pre-diets noveltherapies[J].Ann InternMed, 2004, 40: 627.
[118] LiR,Lindholm K,YangLB, eta1.Amyloid p peptide load is correlatedwith increased secretase activity in sporadicAlzheimers' disease patients[J]. ProcNatlAead SciUSA, 2004, 101: 3632.
[119] Lange-Dohna C, Zeitschel U, Gaunitz F, Perez-Polo JR, Bigl V, Rossner S: Cloning and expression of the rat BACE1 promoter. J Neurosci Res 2003, 73:73-80.
[120] Giardina C, Hubbard AK: Growing old with nuclear factor-kappaB. CellStress Chaperones 2002, 7:207-212.
[121] Toliver-Kinsky T, Wood T, Perez-Polo JR: Nuclear factor kappaB/p49 is anegative regulatory factor in nerve growth factor-induced cholineacetyltransferase promoter activity in PC12 cells. J Neurochem 2000, 75:2241-2251.
[122] Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S, Green EJ, Bethea JR: Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 2005, 202:145-156.
[123] Bales KR, Du Y, Holtzman D, Cordell B, Paul SM: Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E. Neurobiol Aging 2000, 21:427-432;discussion 451-423.
[124] Bourne KZ, Ferrari DC, Lange-Dohna C, Rossner S, Wood TG, Perez-Polo JR: Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides. J Neurosci Res 2007, 85:1194-1204.
[125] edwards mm,robinson sr.tnf alpha affects the expression of gfap and s100b:implications for alzheimer′s disease[j].j neural transm,2006;113(11):170915.
[126]maragakis nj , rothstein jd.mechanisms of disease : astrocytes in neurodegenerative disease[j].nat clin pract neurol,2006;2(12):679.
[127] yin kj,cirrito jr,yan p,et al.matrix metalloproteinases expressed by astrocytes mediate extracellular amyloidbeta peptide catabolism[j].j neurosci,2006;26(43):1093948.
[128] cho hj,kim sk,jin sm,et al.ifngammainduced bace1 expression is mediated by activation of jak2 and erk1/2 signaling pathways and direct binding of stat1 to bace1 promoter in astrocytes[j].glia,2007;55(3):25362.
[129] hong hs,hwang em,sim hj,et al.interferon gamma stimulates betasecretase expression and sappbeta production in astrocytes[j].biochem biophys res commun,2003;307(4):9227.
[130] bourne kz,ferrari dc,langedohna c,et al.differential regulation of bace1 promoter activity by nuclear factorkappab in neurons and glia upon exposure to betaamyloid peptides[j].j neurosci res,2007;85(6):11941204.
[131] hartlagerubsamen m,zeitschel u,apelt j,et al.astrocytic expression of the alzheimer′s disease betasecretase (bace1) is stimulusdependent[j].glia,2003;41(2):16979.
[132] zhao j,paganini l,mucke l,et al.betasecretase processing of the betaamyloid precursor protein in transgenic mice is efficient in neurons but inefficient in astrocytes[j].j biol chem,1996;271(49):3140711.
[2] Dufouil C,Alperobitch A.Epidemiology of Alzheimer's disease[J].Vev Prat,2oo5,55(17):1869-1878
[3] Zhang ZX,Zahner GE,Roman GC,et a1.Socio-demographic variation of dementia subtypes in China: methodology and results of a prevalence study in Beijing,Chengdu,Shanghai,and Xi'an.[J]. Neuroepidemiology,2006,27:177-187
[4]赵湘筠.髓海不足气魄神离—中医对老年性痴呆的认识.上海中医药杂志,1994,(5):24-25.
[5]张映梅.老年痴呆症虚实论治.云南中医中药杂志,2000,21 (6 ):37.
[6]滕晶.补肾化痰祛癖法治疗老年期痴呆机理探讨.河南中医,2003,23 (7):5.
[7]赵文研,陈荣.从脾论治老年性痴呆症.中医药学刊,2005年第23卷第9期:1666.
[8]欧阳真理.老年痴呆的病因病机探讨与治疗.中华实用中西医杂志,2005,18(13):212.
[9]孙明杰,于友华.清热解毒中药防治老年性痴呆症之理论探讨.中国中医基础医学杂志,2003,9 (2 ):17.
[10]郑丽,翟李娟.辨证分型治疗老年痴呆症30例疗效观察.河南中医学院学报,2004,19(4):113.
[11]姜哲浩,夏永良.老年性痴呆病因和发病机制的研究概况.辽宁中医杂志,2001,28(7):446-448
[12]郑丽,翟李娟.辨证分型治疗老年痴呆症30例疗效观察.河南中医学院学报,2004,19(4):113.
[13]赵奕虹,张琳.老年性痴呆辨证论治浅识.实用中医内科杂志,2005, 19 (3):222.
[14]李佰纲,韩秀兰,秦红艳.补肾益精汤治疗老年性痴呆96例.国医论坛,2000,15(3):34-35.
[15]赵文研,陈荣.从脾论治老年性痴呆症.中医药学刊,2005, 23 (9 ): 1665-1666.
[16]杨晓,谢东霞.补肾健脑丸治疗老年性痴呆92例.山西中医,2001, 17(4): 16-17.
[17]张新风.补肾填精汤治疗老年性痴呆30例临床观察.江西中医药,2005,36(12):23.
[18]蔡春华.加味左归丸治疗肝肾阴虚型老年痴呆31例.江苏中医,1994, 15 (11):9
[19]季光,胡梅.老年性痴呆中医治疗现状及展望.1994,7:332.
[20]盛树力,裴进京.老年性痴呆的临床和分子学基础[M].北京:科学技术文献出版社,1998
[21] Hauwj,etal.Alzheimer,5disease. In:Suektted[J]. The Pathologyofagingnervous Systern.London:leadF ebiger,1991,113
[22]Braa,etal.NeuroPathologiealstagingofAlzheimer一relatedehanges[J].AetaNeuroPathol.1991,82:239-256
[23]李求兵,梅荣.老年痴呆症的中西医诊断与治[M].北京:中国医药科技出版社,1999
[24] Liswixb J. A mechanism for the Hebb processes underlying learning and memory. Pro Nall Acard Sci USA,1989,86:9576.
[25] Jesus Avila, Mar Perez, Jose J, etal. Assembly In Vitro of Tau Protein and its implications in Alzheimer's Disease Current Alzheimer Research,2004, 1(7);97-101.
[26]高天理,冯立群,张茁.Tau蛋白在Alzheimer病病理机制中作用的研究进展.北京医学,2001, 23 (6) ; 365-367.
[27]江天,琦组和.载脂蛋白E与Alzheiner病的分子生物学研究新进展.中国老年医学杂志,1998, 17 (8) 8-189.
[28] Tomonaga M.et al.Numbers of Hirano bodies[J].Acta Neuropathol,1999,28:365-366.
[29] Sherns G, Sez Valero J, Beyreuther K, et al.The amyloid beta-protein of Alzheimer’s disease increase acetylcholinesterase carcinoma P19 cells. J Neurochem , 1997 ,69:1177-1184.
[30] Hoozemans JJ, Rozemuller AJ, Veerhuis R,Immunological aspects of alzheimer's disease: therapeutic impl icat ions. BioDrugs, 2001; 15(5):325-37
[31]姜哲浩,夏永良,李德新.老年性痴呆病因和发病机制的研究概况[J].辽宁中医杂志,2001,28(7 ) : 446-448
[32]杨文明,李泽庚,周宜轩,等.老年性痴呆病因及药物治疗[J].医学综述,2002,8(3):170-172
[33] Hauw JJ, et al,Alzheimer s disesse.In:Sucktted.The Pathology of aging nervous Systern.London: lea and Febiger,1991,113.
[34] Tabaton M,er al.Ultrastructural localization ofβ-amyoid,tau and ubiduitin epitopes in extracellular neurofibrillary tangles[J].Proe Natl Acad sci USA,1991,88:2098-2102.
[35] Bondareff E,et al.Molecular analysis of neurofibrillary degeneration in Alzheimer’s disease[J].Am J Pathol,2003,137:711-723
[36] Terry RD.Normal aging ang Alzhenmer’s disease:growing problems In: PA Cancilla,FVS Vohel and N Kaufman eds[J].Neropathology Baltimore:Willams ang Wilkins,1999,41-54.
[37] Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC:Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am JPathol 2004, 164:719-725.
[38] Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, ha H,Zhang J, Gong Y, et al: Mice deficient in BACE1, the lzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.Nat Neurosci 2001, 4:231-232.
[39] Mohaj eri MH, Saini KD, Nitsch RM:Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology. J Neural Transm 2004,111:413-425.
[40] Itagaki S,McGeer PL,Akiyama H,et al.Relationship of microglia and astrocytes to amyloid deposits of Alzheimer’s disease[J].J Neuroimmunol, 1989,24(3):173-182.
[41] Joshi SN,Crutcher KA.Rat microglia exhibit increased density on Alzheimer’s plaques in vitro[J].Exp Neurol,1998,149(1):42-50.
[42]魏桂荣,张敏,董继华,等.构建一种高产量小胶质细胞体外纯化培养的方法[J].中国临床康复,2005,9(21):208-210.
[43]陈青,刘传勇.星形胶质细胞的活化机制及功能研究.泰山医学院学报,2006,27:69-71.
[44] LH , YingTM , FangM , etal.Thediffereneein9110515indueedbyp amyloidandTau Treatmentsina stroeytecultures derivedfromseneseen ceaeeelerate dandnormal mouse strains.SPringerSeienee BusinessMediaB.V,2009(2).
[45] RobertGN,VenkatR,etal.Contributionofglialeellsto the evelo Pmentof amyloidPlaquesin Alzheimer,5disease.BrainResearch,2003,971:197-209.
[46] Stenzel W,Soltek S,Schlüter D,et a1·The interme-diate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis[J].J Neu-ropathol Exp Neurol,2004,63(6):631-640.
[47] Hoane M R,Wolyniak J G,Akstulewicz S L.Admin istration of riboflavin improves behavioral outcome and reduces edema formation and glial fibrillary acidicprotein expression after traumatic brain injury[J].J Neurotrauma,2005,22(10):1112-1122.
[48] Tanaka H,Katoh A,Oquro K,et al.Disturbance of hippocampals long-term potentiation after transient ischemia in GFAP deficient mice[J].J Neurosci Res, 2002,67(1):11-20.
[49] Endo T.Glycans and glycan-binding proteins in brain:galectin-1-induced expression of neurotrophic factors in astrocytes[J].Curr Drug Targets,2005,6(4):427-436.
[50] Nichols N R,Agolley D,Zieba M,et al·Glucocorticoid regulation of glial responses during hippocampal neu-rodegeneration and regeneration[J].Brain Res Brain Res Rev,2005,48(2):287-301.
[51] Temburni M K,Jacob M H.New functions for glia in the brain[J].Proc Natl Acad SciUSA,2001,98 (7):3631-3632.
[52] Min K J,Yang M S,Jou I,et al.Protein kinase A medi-ates microglial activation induced by plasminogen and gangliosides[J].Exp Mol
[53] Albrecht P J, Dahl J P, Stoltzfus O K, et al. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival [J].Exp Neurol,2002,173(1):46-62.Med,2004,36(5):461-467.
[54] Beattie E C,Stellwagen D,Morishita W,et al.Controlof synaptic strength by glial TNF alpha[J].Science, 2002,295(5563):2282-2285.
[55]王建彪,竺可青.星形胶质细胞对神经元作用的研究进展[J].浙江大学学报:医学版,2008,37(5):531-536.
[56] Soler AP,Thompson KA,Jarett L.Immunological demonstration of the accumulation of insulin,but not insulin receptors,in nuclei of insulin-treated cells.Proc Natl Acad Sci USA,1989,86:6640-6644.
[57] Harris ME Hensley K Butterfield DA,et al.Direct evidence of oxidative injury produced by the Alzheimer'sbeta-amyloid peptide(1-40)in cultured hippo cam palneurons. Exper Neuro[J].1 1995,131(2):193~200。
[58] Rogers SL,Doody R , et a1.E2020 produced both clinical global and cognitive testimprovement in patient with mild to moderately sever Alzheimer's disease: results of a30一weeks phaseIIItrial[J].Neurology,1996,(46):217.
[59] DAIE S,BARBOUR R,DUNN W,et al·Immunization with amyliod Battenuates Alzheimer disease-like pathology in the PDAPP mouse[J].Nature,1999,400(6740):173一177.
[60] Cynthia Lemere.notherapy for Alzheimer's Disease. Neurobiology of Aging, 2002 (23):986
[61] Blas Frangione. Modification of Soluble AβDerivativer: An Approach to Alzheimer's disease Therapy. Neurobiology of Aging, 2002, (23):987
[62] Martin Citron.β-Secretase Inhibitor Therapy for Alzheimer's as therapy for Alzheimer's Disease.Neurobiology of Aging, 2002, (23):991
[63] Sangram Sisodia.Current Status of Emerging Therapise for Alzheimer's Disease" Neurobiology of Aging,2002, (23):992
[64] Ashley Bush. Metal Complexing Agents as Therapies for Alzheimer;s Disease. Neurobiology of Aging,2002 (23):988
[65] Sam Gandy.Gonadal Hormones in the prevention of Alzheimer's disease. Neurobiology ofAging,2002,(23):989
[66] Virginia M. Y. Lee. Amyloid Binding Ligands as Alzheimer; s Disease Therapies. Neurobiology of Aging 2002, (23):990
[67] Sani S, Traul D, Klink A, et al. Distribution, progression and chemical composition of cortical amyloid-beta deposits in aged rhesus monkeys: similarities to the human. Acta Neuropathol(Beri), 2003,105(2): 145一156
[68] Nitta A, Itoh A, Hasegawa T,et al. 0 -amyloid protein induced Alzheimer's disease animal model.Neurosci Lett,1994,170(1):63-66
[69]崔行,王墨林,张群业.胆碱能系损伤老化鼠的脑神经肤表达与学习能力改变.中国老年学杂志,2002,22:379-381
[70] Giovannelli L,Cassamenti F,Scall C,et al. Differential effects of amyloid peptides p一(1-40) and一(25-35) injection into the rat mucles basalis. Neuroscience, 1995, 66:781一792
[71]程龙,田金州,黄启福.β一淀粉样蛋白所致拟AD大鼠模型行为学特征.中华医药杂志,2003,3(6)481-484
[72] Cakala M, Malik AR, Strosznajder JB. Inhibitor oof cyclooxygenase-2 protects against amyloid beta peptide-evoked memory impairment in mice. Pharmacol Rep, 2007,59(2):164-172
[73]林煌,王占军,陈俊抛,等.海马注射β一淀粉样蛋白对白介素-10和肿瘤坏死因子-a表达的影响及消炎痛的干预作用.中国神经免疫学和神经病学杂志,2002,9(1):21-24
[74] Kim HC, Yamada K, Nitta A, et al. Immunocy to chemical evidence that amyloid
[75] Deng HX, Siddique T. Transgenic Mouse Models and Human Neurodegenerative Disorder. Arch Neurol, 2000, 57(12):1695一1702
[76] Donald LP, Sangram SS. Cellular and molecular biology of Alzheimer's disease and animal models. Ann Rev Med, 1994,45:435-436
[77] Eilam D, Szechtman H, Faigon M, et al. Disintergration of the spaticalorganization of behavior in experimental autoimmune dementia. Neuroscience,1993,56:83一91
[78] Morris RG.Spatial localization does not require the presence of localcues[J].Learn Motiv,1981,12:239-60.
[79] Gallagher N,Nicolleo MM.Animal model of normal aging:relationship between congnitive decline and marker in hippocampal crcuity[J].Brain Research,1993,57:155-62
[80]DelacourteABueeL.Taupath01ogy:neurodegenerativedisorders.Curr.OPin.Neuro,2002,13,3712一3761
[81] Ball MJ.Neuronal loss,neurofibrillary tangles and granulovacuolar degeneration in the hippocampuuus with ageig brain and senile dementia .Aquantitative study[J].Acta Neuropathol,1977,37:111-118.
[82]蒋圣娟,孙振令,张红雨.阿尔茨海默氏症分子病理学及治疗方法的研究进展.山东理工大学学报(自然科学版),2003,17(1):94-99.
[83] DewachterI,VanDorpe J, SmeijersL, eta.l Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenicmice by a differentmechanism thanmutantpresenilin1·J Neurosc,i 2000,20(17):6452-6458.
[84] Kuo, Y.M., Beach, T. G., Sue, L. I., et a.l The evolution ofAβpeptide burden in the APP23 transgenic mice: implications forAβdeposition inAlzheimerdisease.Mo.lMed, 2001, 7:609-618.
[85] Kang J,Lemaire HG,Unterbeck A,et al.The precursor of Alzheimer’sdisease amyloidA4 protein resembles a cell surface receptor.Nature,1987,325:733~736
[86] Klein WL,Krafft GA,Finch CE.Targeting small Abeta oligomers:thesolution to an Alzheimer's disease conundrum?Trends Neurosci,2001,24(4):219~224
[87] Walsh DM,Klyubin I,Fadeeva JV,etal.Naturally secreted oligomers ofamyloid beta protein potently inhibit hippocampal long-term potentiationin vivo.Nature,2002,416(6880):535~539
[88] Cleary JP,Walsh DM,Hofmeister JJ,etal.Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function.Nat eurosci, 2005,8(1):79~84
[89] Hussain I,Powell D,Howlett DR,etal.Identification of a novel aspartic protease(Asp 2)as beta-secretase.Mol Cell Neurosci,1999,14(6):419~27
[90] Lin X,Koelsch G,Wu S,etal.Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.Proc Natl Acad Sci U S A,2000,97(4):1456~1460
[91] Sinha S,Anderson JP,Barbour R,etal.Purification and cloning of amyloid precursor protein beta-secretase from human brain.Nature,1999, 402(6761):537~540
[92] Cai H,Wang Y,McCarthy D,etal.BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.Nat Neurosci,2001,4(3):233~234
[93] Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, ha H,Zhang J, Gong Y, et al: Mice deficient in BACE1, the lzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.Nat Neurosci 2001, 4:231-232.
[94] Ingebrigtsen,Hughes S R,khorkova O,Goyal S,et al. Alpha-macrogloblin associates with b-amyloid peptide and prevents of fibril formation , proc Natl Acad Sci USA ,1998(95):3275-3280.
[95] Mucke L, Masliah E, Yu GQ, et al. High-level neuroal expression of abeta 1-42 in wild-type human amyloid protein precursor transgentic mice: synaptotoxicity without plaque formation. Neurosci ,2000,20:4050-4058.
[96] Yankner BA,Duffy LK,Kirschner DA.Neurotrophic and neurotoxic ef fects of amyloid protein:reversal by tachkinin neuropeptides.Science,1990,250(4978):279-282.
[97] Calderon FH, Bernhard R, et al. Toxic effects of acetylcholinesterase on neuronal and glial-like cells in vitro. Mol Psychiarry,1998,3(3):247-255.
[98] Petrova,Terry RD. Basis of structural Alzheimer Disease and some pathogenic concepts. In:R Becker and E Giacobinieds.Alzheimer Disease: From molecular biology to therapy. Boston: Birkhauser,1997,19:25-28.
[99] Min K J,Yang M S,Jou I,et al.Protein kinase A medi ates microglial activation induced by plasminogen and gangliosides[J].Exp Mol Med,2004,36(5):461-467.
[100] Albrecht P J, Dahl J P, Stoltzfus O K, et al. Ciliary neurotrophic factor activates spinal cord astrocytes,stimulating their production and release of fibroblast growth factor-2,to increase motor neuron survival[J].Exp Neurol,2002,173(1):46-62.
[101] Beattie E C,Stellwagen D,Morishita W,et al.Control of synaptic strength by glial TNF alpha[J].Science,2002,295(5563):2282-2285.
[102]王建彪,竺可青.星形胶质细胞对神经元作用的研究进展[J].浙江大学学报:医学版,2008,37(5):531-536.
[103] Stenzel W,Soltek S,Schlüter D,et a1 The interme- diate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis[J].J Neuropathol Exp Neurol,2004,63(6):631-640.
[104] Hoane M R,Wolyniak J G,Akstulewicz S L.Admin istration of riboflavin improves behavioral outcome and reduces edema formation and glial fibrillary acidic protein expression after traumatic brain injury[J].JNeurotrauma,2005,22(10):1112-1122.
[105] Tanaka H,Katoh A,Oquro K,et al.Disturbance ofhippocampals long-term potentiation after transientischemia in GFAP deficient mice[J].J Neurosci Res,2002,67(1):11-20.
[106] Endo T.Glycans and glycan-binding proteins in brain:galectin-1-induced expression ofneurotrophic factors in astrocytes[J].Curr Drug Targets,2005,6(4):427-436.
[107] Nichols N R,Agolley D,Zieba M,et al·Glucocorticoid regulation of glial responses during hippocampal neurodegeneration and regeneration[J].Brain Res Brain Res Rev,2005,48 (2):287-301.
[108] Temburni M K,Jacob M H.New functions for glia in the brain[J].Proc Natl Acad Sci USA,2001,98 (7):3631-3632.
[109] O’Neill LAJ , Kaltschmidt C. NF - kB a crucial transcription factor forglial and neuronal cell function. Trends Neurosci ,1997 ,20 :252～258.
[110] Mattson MP,Culmsee C,Yu Z,Camandola S.Roles of nuclear factor kappaB inneuronal survival and plasticity[J].J Neurochem,2000,74:443-456
[111] Culmsee C,Siewe J,Junker V,Retiounskaia M,Schwarz S,Camandola S,et al.Reciprocal Inhibition of p53 and Nuclear Factor-κB Transcriptional Activities Determines Cell Survival or Death in Neurons[J].J Neurosci,2003,23:8586-8595.
[112] Middleton G,Davies AM,et al.Cytokine-induced Nuclear Factor Kappa BActivation Promotes the Survival of Developing Neurons[J].J Cell Biol,2000,148:325-332.
[113] Lilienbaum A,Isra?l A.From Calcium to NF-B Signaling Pathways in Neurons[J].Mol Cell Biol,2003,23:2680-2698.
[114] Boissiere F ,Hunot S ,Faucheaux B et al . Nuclear translocation of NF -kappa B in cholinergic neurons of patients with Alzhecmer’s disease.Neuroreport ,1997 ,8(13) :2849～2852
[115]冯凯琳,陈宝友,陈彦亭等.核转录因子NF - kB与中枢神经系统疾病[J].武警医学.2002.4:236 [ 116] M aurelD, SageD. M ekaoucheM, eta.l Glucocorticoids up - regu-late the expression of glial f ibrillary acidic protein in the rat suprachi-asm atic nucleus[J].Glia, 2000, 29 (3): 212.
[117] Selkoe DJ. American college of physicians, American physiologi-calsociety. Alzheimer disease:mechanistic understanding pre-diets noveltherapies[J].Ann InternMed, 2004, 40: 627.
[118] LiR,Lindholm K,YangLB, eta1.Amyloid p peptide load is correlatedwith increased secretase activity in sporadicAlzheimers' disease patients[J]. ProcNatlAead SciUSA, 2004, 101: 3632.
[119] Lange-Dohna C, Zeitschel U, Gaunitz F, Perez-Polo JR, Bigl V, Rossner S: Cloning and expression of the rat BACE1 promoter. J Neurosci Res 2003, 73:73-80.
[120] Giardina C, Hubbard AK: Growing old with nuclear factor-kappaB. CellStress Chaperones 2002, 7:207-212.
[121] Toliver-Kinsky T, Wood T, Perez-Polo JR: Nuclear factor kappaB/p49 is anegative regulatory factor in nerve growth factor-induced cholineacetyltransferase promoter activity in PC12 cells. J Neurochem 2000, 75:2241-2251.
[122] Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S, Green EJ, Bethea JR: Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 2005, 202:145-156.
[123] Bales KR, Du Y, Holtzman D, Cordell B, Paul SM: Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E. Neurobiol Aging 2000, 21:427-432;discussion 451-423.
[124] Bourne KZ, Ferrari DC, Lange-Dohna C, Rossner S, Wood TG, Perez-Polo JR: Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides. J Neurosci Res 2007, 85:1194-1204.
[125] edwards mm,robinson sr.tnf alpha affects the expression of gfap and s100b:implications for alzheimer′s disease[j].j neural transm,2006;113(11):170915.
[126]maragakis nj , rothstein jd.mechanisms of disease : astrocytes in neurodegenerative disease[j].nat clin pract neurol,2006;2(12):679.
[127] yin kj,cirrito jr,yan p,et al.matrix metalloproteinases expressed by astrocytes mediate extracellular amyloidbeta peptide catabolism[j].j neurosci,2006;26(43):1093948.
[128] cho hj,kim sk,jin sm,et al.ifngammainduced bace1 expression is mediated by activation of jak2 and erk1/2 signaling pathways and direct binding of stat1 to bace1 promoter in astrocytes[j].glia,2007;55(3):25362.
[129] hong hs,hwang em,sim hj,et al.interferon gamma stimulates betasecretase expression and sappbeta production in astrocytes[j].biochem biophys res commun,2003;307(4):9227.
[130] bourne kz,ferrari dc,langedohna c,et al.differential regulation of bace1 promoter activity by nuclear factorkappab in neurons and glia upon exposure to betaamyloid peptides[j].j neurosci res,2007;85(6):11941204.
[131] hartlagerubsamen m,zeitschel u,apelt j,et al.astrocytic expression of the alzheimer′s disease betasecretase (bace1) is stimulusdependent[j].glia,2003;41(2):16979.
[132] zhao j,paganini l,mucke l,et al.betasecretase processing of the betaamyloid precursor protein in transgenic mice is efficient in neurons but inefficient in astrocytes[j].j biol chem,1996;271(49):3140711.